This FDA-approved treatment for weight loss, also known as Zepbound, is a powerful tool in managing obesity by targeting two crucial hormones that regulate appetite and blood sugar
Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30
It is prescribed for individuals with a BMI (Body Mass Index) of 27 or higher, provided they have weight-related conditions such as Type 2 Diabetes, High Blood Pressure, and Sleep Apnea
DURING THE WASHOUT PERIOD If a glucocorticoid is administered during the Out-of-Competition period, but the competition will occur within the washout period, the following procedure should be followed: Complete the appropriate medical record documentation at the time of administration to include: history, physical examination, diagnosis, clinical investigations, medication name, dosage, route of administration, and duration of treatment